Bank of Montreal
BSTG

Bank of Montreal’s Biostage, Inc. Common Stock BSTG Stock Holding History

Bank of Montreal’s Portfolio BSTG Stock Details BSTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-160
Closed -$2K – 4682
2014
Q2 		$2K Buy
+160
New +$1.36K ﹤0.01% 4543

Other funds holding BSTG

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $434M AUM 19.64% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of Montreal's BSTG Position: Q3 2014 in Review

Bank of Montreal sold out of Biostage, Inc. Common Stock (BSTG) in Q3 2014, closing a stake of 160 shares — an estimated $2K sold.

Bank of Montreal first reported a position in BSTG in Q2 2014 and held it in 1 quarter. The position peaked at $2K in Q2 2014. 43 funds tracked by Wall St. Rank hold BSTG as of Q3 2014.

  • Bank of Montreal reported no remaining Biostage, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • Bank of Montreal sold 160 Biostage, Inc. Common Stock shares in Q3 2014, an estimated $2K.
  • Bank of Montreal first reported a position in Biostage, Inc. Common Stock in Q2 2014 and held it in 1 quarter.
  • Bank of Montreal's Biostage, Inc. Common Stock position peaked at $2K in Q2 2014.
  • 43 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q3 2014.

Based on Bank of Montreal's 13F filing for Q3 2014, filed 7 Nov 2014.